Vaxess
PrivateLast Round
Series C
Mar 27, 2026
Total Funding Raised
$120.3M
Momentum Score
25 /100
Company Overview
Vaxess Technologies is a biotechnology company that develops innovative therapies aimed at enhancing oncology care and combating infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Advanced Materials, Pharma Supply Chain
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vaxess Comps
Public and private peers based on sector, stage, and business model.
Vaxess Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 27, 2026 | ||||
| Early Funding | Apr 9, 2025 | ||||
| VC Round | May 22, 2024 | ||||
| Early Funding | Sep 13, 2023 | ||||
| Series B Extension | Jan 10, 2023 | ||||
Series B | Nov 2, 2022 |
Vaxess Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series B |
| RA Capital Management | Early Funding, VC Round, Series B Extension, Series B, Series C |
| The Engine | Series B, Early Funding, Series B Extension, Series A |
| Engine Ventures | Series C |
| BioInnovation Capital | Series A, Series B Extension |
| Massachusetts Life Sciences Center | Debt |
| The Bill & Melinda Gates Foundation Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 27, 2026
$50M Series C round raised.
- Jan 1, 2026
Supporting Phase 2 and Phase 3 clinical manufacturing.
Vaxess Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vaxess's valuation, stock price, and market status.
